IMPORTANCE OF CLASSIFYING INITIAL CO-MORBIDITY IN EVALUATING OUTCOME OF DIABETES-MELLITUS

被引:512
作者
KAPLAN, MH
FEINSTEIN, AR
机构
[1] YALE UNIV, SCH MED, NEW HAVEN, CT 06520 USA
[2] VET ADM HOSP, EASTERN COOPERAT STUDIES CTR, WEST HAVEN, CT USA
[3] YALE UNIV, HLTH SERV, NEW HAVEN, CT USA
来源
JOURNAL OF CHRONIC DISEASES | 1974年 / 27卷 / 7-8期
关键词
D O I
10.1016/0021-9681(74)90017-4
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
引用
收藏
页码:387 / 404
页数:18
相关论文
共 14 条
[1]  
BERKSON J, 1950, P STAFF M MAYO CLIN, V25, P270
[3]  
CUTLER SJ, 1958, J CHRON DIS, V8, P699
[4]  
Feinstein A. R, 1967, CLIN JUDGMENT
[5]   EPIDEMIOLOGY OF CANCER THERAPY .2. CLINICAL COURSE - DATA DECISIONS AND TEMPORAL DEMARCATIONS [J].
FEINSTEIN, AR ;
PRITCHETT, JA ;
SCHIMPFF, CR .
ARCHIVES OF INTERNAL MEDICINE, 1969, 123 (03) :323-+
[6]   CLINICAL EPIDEMIOLOGY .3. CLINICAL DESIGN OF STATISTICS IN THERAPY [J].
FEINSTEIN, AR .
ANNALS OF INTERNAL MEDICINE, 1968, 69 (06) :1287-+
[7]  
FEINSTEIN AR, 1971, CLIN PHARMACOL THER, V12, P134
[8]   PRE-THERAPEUTIC CLASSIFICATION OF CO-MORBIDITY IN CHRONIC DISEASE [J].
FEINSTEIN, AR .
JOURNAL OF CHRONIC DISEASES, 1970, 23 (07) :455-+
[9]  
FEINSTEIN AR, 1972, CLIN PHARMACOL THER, V13, P755
[10]  
FEINSTEIN AR, 1971, CLIN PHARMACOL THER, V12, P864